SCHEMBL8288509

SCHEMBL8288509

CC(C)S(=O)(=O)Nc1ccccc1-c1ccc(-c2cn(C)nc2C#N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.42
FEN1 P39748 2/20 0.42
PGR P06401 1/20 0.40
STAT3 P40763 2/20 0.39
MAPK1 P28482 2/20 0.38
SLC22A12 Q96S37 3/20 0.34
LMNA P02545 2/20 0.34
MCOLN3 Q8TDD5 2/20 0.34
CA12 O43570 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34
TUBB8 Q3ZCM7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4369437 0.78 GRIA4 (0.38) ALOX5APFEN1PGRSTAT3GRIA4
SCHEMBL6513336 0.74 MCOLN3 (0.55) ALOX5APFEN1LMNAMCOLN3CA12
SCHEMBL4374866 0.73 ESR2 (0.50) MAPK1NR3C1GRIA4GRIA2
SCHEMBL8288516 0.72 ALOX5AP (0.39) ALOX5APFEN1PGRSTAT3SLC22A12
SCHEMBL8289547 0.72 GRIA4 (0.42) ALOX5APFEN1PGRSTAT3TUBB4A
SCHEMBL4372551 0.72 ALDH1A1 (0.42) MAPK1LMNASMN1; SMN2
SCHEMBL4374171 0.72 ALOX5AP (0.52) ALOX5APFEN1STAT3MAPK1LMNA
SCHEMBL4372212 0.70 GRIA2 (0.43) ALOX5APFEN1MAPK1LMNAGRIA4
SCHEMBL4372547 0.70 BCAT2 (0.49) ALOX5APFEN1MAPK1
SCHEMBL13612301 0.70 GRIA4 (0.62) GRIA4GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625932-B2 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors ELI LILLY AND COMPANY (US) 2009-12-01 US disclosed
EP-1670757-B1 PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS LILLY CO ELI (US) 2009-05-06 EP disclosed
US-20070066573-A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors ELI LILLY AND COMPANY 2007-03-22 US disclosed
WO-2005040110-A1 PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS ELI LILLY AND COMPANY (US) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066573-A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors GRIN1, GRIN3A, GRIK5 ALOX5AP 1152/4885FEN1 3482/4885PGR 199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.